Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2023
March
07
Modifying messenger RNA provides new Alzheimer’s disease target
Veracyte sees revenue growth in oncology classifiers, new genomic products, global expansion
Study supports genetic testing for people with cerebral palsy
DermTech obtains melanoma testing coverage for additional 1.9 million people
FDA grants clearance to Abbott for first commercial laboratory test to detect traumatic brain injury
Page 1 of 1